Mirum Pharmaceuticals, Inc. MIRM Decrease in ROU assets and lease liabilities due to lease modification
Decrease in ROU assets and lease liabilities due to lease modification at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mirm:RightOfUseAssetAndLeaseLiabilitiesDecreaseDueToLeaseModification.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s decrease in rou assets and lease liabilities due to lease modification.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s decrease in ROU assets and lease liabilities due to lease modification?
- Mirum Pharmaceuticals, Inc. (MIRM) reported decrease in ROU assets and lease liabilities due to lease modification of $0 in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s decrease in ROU assets and lease liabilities due to lease modification changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s decrease in ROU assets and lease liabilities due to lease modification decreased by 100.0% year-over-year, from $649K to $0.
- What does decrease in ROU assets and lease liabilities due to lease modification mean?
- Represents the net reduction in right-of-use assets and corresponding lease liabilities resulting from modifications to existing lease agreements. This metric captures non-cash adjustments to the balance sheet when lease terms, scope, or duration are formally altered. It provides insight into how management optimizes real estate or equipment footprints to align with operational needs.